Microbiology Quiz: Biosafety Levels And Lab Safety
20 questions · exam conditions
0:00
Biosafety Levels And Lab SafetyQuestion 1 of 20

A clinical laboratory receives a sealed, intact blood culture bottle that flags positive. A Gram stain reveals gram-negative rods. The lab's standard operating procedure is to subculture the bottle in a BSL-2 facility. However, if the isolate is later identified as Francisella tularensis, an unexpected BSL-3 agent, which initial step in processing posed the greatest risk of a laboratory-acquired infection?

Performing the Gram stain, which involves heat-fixing the slide on a slide warmer.
Inserting a needle into the septum of the blood culture bottle to withdraw an aliquot for subculture.
Streaking the withdrawn blood onto agar plates on an open bench.
Uncapping the positive blood culture bottle to perform a direct MALDI-TOF identification.
← Back to quizzes

Microbiology Quiz

Microbiology Quiz: Biosafety Levels And Lab Safety

Practice Biosafety Levels And Lab Safety in Microbiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Biosafety Levels And Lab Safety, giving you a quick way to practice the rules, question types, and explanations that matter most for Microbiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A clinical laboratory receives a sealed, intact blood culture bottle that flags positive. A Gram stain reveals gram-negative rods. The lab's standard operating procedure is to subculture the bottle in a BSL-2 facility. However, if the isolate is later identified as Francisella tularensis, an unexpected BSL-3 agent, which initial step in processing posed the greatest risk of a laboratory-acquired infection?

  1. Performing the Gram stain, which involves heat-fixing the slide on a slide warmer.
  2. Inserting a needle into the septum of the blood culture bottle to withdraw an aliquot for subculture.
  3. Streaking the withdrawn blood onto agar plates on an open bench. (correct answer)
  4. Uncapping the positive blood culture bottle to perform a direct MALDI-TOF identification.
Explanation: The correct answer is C. Streaking an inoculum onto an agar plate is a common procedure that can generate infectious aerosols, especially with a loop or needle. When dealing with an unknown but potentially high-risk pathogen like F. tularensis (which has a very low infectious dose via inhalation), performing this manipulation on an open bench creates a significant risk of exposure for the technologist. All unknown positive blood cultures should ideally be subcultured within a BSC. A is a lower risk. While heat-fixing can create some aerosols, the number of viable organisms aerosolized is typically much lower than during culture manipulation. B is a relatively low-risk procedure. Using a needle and syringe through a rubber septum is designed to minimize aerosol production and is a standard, safe technique. D, while also a manipulation with an open bottle, is often performed on a small spot and is a less vigorous action than streaking a plate, which involves moving the inoculum across a wide surface area. However, the most fundamental and high-risk procedure among the choices that is routinely performed is the open-bench subculture (streaking).

Question 2

A researcher needs to decontaminate a piece of sensitive electronic equipment from a BSL-3 lab that cannot tolerate the heat and moisture of an autoclave. The equipment is contaminated with a spore-forming bacterium. Which decontamination method would be most appropriate and effective?

  1. Wiping the surface thoroughly with 70% ethanol and allowing it to air dry.
  2. Exposing the equipment to a high dose of ultraviolet (UV-C) radiation for 30 minutes.
  3. Soaking the equipment in a 2% glutaraldehyde solution for 20 minutes.
  4. Fumigating the equipment in a sealed chamber using vaporized hydrogen peroxide (VHP). (correct answer)
Explanation: When dealing with spore-forming bacteria in a BSL-3 setting, you need a sporicidal method that's compatible with sensitive electronics. This question tests your understanding of decontamination methods and their limitations with different materials and microorganisms. Vaporized hydrogen peroxide (VHP) fumigation is the ideal choice here because it provides sporicidal activity without the damaging heat and moisture of autoclaving. VHP penetrates into crevices and surfaces while remaining gentle enough for electronic equipment. The vapor phase ensures even distribution and compatibility with sensitive components, making it the gold standard for decontaminating electronics in high-containment laboratories. Option A (70% ethanol) is ineffective against bacterial spores. While ethanol works well against vegetative bacteria and enveloped viruses, spores have protective coats that resist alcohol-based disinfectants. This would leave viable spores on the equipment. Option B (UV-C radiation) has significant limitations for complex equipment. UV only works on directly exposed surfaces and cannot penetrate shadows, crevices, or internal components where spores might hide. Electronic equipment typically has many areas where UV cannot reach effectively. Option C (2% glutaraldehyde) would be sporicidal, but soaking electronic equipment in liquid would cause severe damage to circuits, connections, and components. The physical incompatibility makes this option impractical despite its antimicrobial effectiveness. For microbiology exams, remember that spore decontamination requires either extreme heat, strong chemicals, or specialized methods like VHP. Always consider both the antimicrobial efficacy and material compatibility when selecting decontamination methods for sensitive equipment.

Question 3

During a procedure in a BSL-2 lab, a researcher working in a Class II BSC accidentally knocks over a flask of media, which splashes onto their gloved hands and lab coat sleeves. The researcher is working with a non-pathogenic strain of E. coli. According to best practices, what is the most appropriate immediate action?

  1. Stop work, change gloves using a technique that avoids touching the outside of the old gloves, and replace the lab coat. (correct answer)
  2. Continue working after wiping the gloves and sleeves with 70% ethanol, since the organism is non-pathogenic.
  3. Immediately exit the lab and remove the contaminated lab coat and gloves in the hallway to prevent further spread.
  4. Alert the supervisor, evacuate the area, and allow aerosols to settle for 30 minutes before initiating a full cabinet decontamination.
Explanation: When you encounter biosafety questions, focus on understanding containment levels and proportional responses. The key is matching your response to the actual risk level, not overreacting to minor spills. Answer A is correct because it follows proper BSL-2 protocols for a minor splash incident. The aseptic glove removal technique (pulling the first glove off by gripping the outside, then using the clean inner surface to remove the second glove) prevents hand contamination. Changing the lab coat eliminates the contaminated surface. This measured response is appropriate for a small spill of non-pathogenic organisms in a controlled environment like a Class II BSC. Answer B is wrong because even non-pathogenic organisms require proper decontamination procedures. Simply wiping with ethanol doesn't guarantee complete removal and violates BSL-2 protocols that require protective equipment changes after contamination. Answer C is incorrect because removing contaminated PPE outside the lab actually spreads contamination to uncontrolled areas. PPE should always be removed within the appropriate containment zone where decontamination systems are available. Answer D represents a massive overreaction. This response would be appropriate for high-risk pathogens or large spills with significant aerosol generation, but a simple splash of non-pathogenic E. coli doesn't warrant area evacuation or extended settling times. Remember that biosafety responses should be proportional to risk. BSL-2 organisms require standard precautions, but don't confuse these protocols with BSL-3 or BSL-4 emergency procedures. Practice distinguishing between routine decontamination and true emergency responses.

Question 4

A fire alarm is activated in a building that houses a BSL-4 suit laboratory. Personnel are inside the maximum containment area working with a lethal virus. The facility's emergency action plan must balance immediate life safety with biocontainment. Which of the following actions represents the most appropriate response for the personnel inside the BSL-4 lab?

  1. Immediately evacuate through the nearest emergency exit, bypassing all standard decontamination procedures.
  2. Secure all infectious materials in a BSC, power down non-essential equipment, and proceed through the standard chemical decontamination shower exit. (correct answer)
  3. Move to a designated 'safe room' within the containment zone and await instructions from emergency responders.
  4. Initiate emergency whole-room fumigation to neutralize the agent before evacuating through the chemical shower.
Explanation: The correct answer is B. Emergency plans for BSL-4 labs are complex and highly specific, but they are built on the principle of a safe and controlled exit whenever possible. The standard procedure in the event of a fire alarm (in the absence of immediate, direct personal danger like flames in the room) is to follow a controlled shutdown. This involves securing agents, shutting down BSCs, and exiting via the mandatory chemical shower to decontaminate the positive-pressure suits. This process is practiced to be as rapid as possible while maintaining containment. A is incorrect. Bypassing decontamination would risk releasing the BSL-4 agent into the environment, which could cause a public health catastrophe. This is only considered in the most extreme, life-or-death situations where the exit path is compromised. C is incorrect. While waiting for instructions might seem prudent, it delays evacuation in a potential fire. The protocol is to initiate a controlled exit. D is incorrect because whole-room fumigation takes hours and would be completely inappropriate during a fire emergency.

Question 5

The CDC's Select Agent Program imposes requirements beyond those dictated solely by an agent's Risk Group and BSL designation. A facility that handles Bacillus anthracis (a Select Agent) must implement which of the following administrative controls that is not required for a facility handling an otherwise equivalent BSL-3 non-select agent?

  1. Maintaining detailed logs of all personnel who access the BSL-3 laboratory.
  2. Requiring personnel to receive specialized training on the hazards of the specific agent.
  3. Developing a comprehensive emergency response plan for spills and personnel exposures.
  4. Undergoing a security risk assessment and clearance for all personnel with access to the agent. (correct answer)
Explanation: The correct answer is D. The Select Agent Program is primarily concerned with biosecurity (preventing theft, loss, or intentional misuse of dangerous pathogens) in addition to biosafety. A key requirement of this program is that all individuals with access to Select Agents must undergo a Security Risk Assessment (SRA) conducted by the Department of Justice/FBI. This is a unique administrative control that does not apply to non-select agents, even those handled at the same biosafety level. A, B, and C are all standard and essential components of a robust biosafety program for any BSL-3 laboratory, regardless of whether the agent is a Select Agent or not. While the stringency and documentation may be higher for Select Agents, the requirement for access logs, specific training, and emergency plans is fundamental to all BSL-3 work.

Question 6

A lab worker in a BSL-3 facility experiences a needlestick injury with a syringe containing a live, attenuated vaccine strain of a pathogen. The lab's risk assessment has determined this vaccine strain to be a Risk Group 2 agent. What is the most critical flaw in assuming this work can be done at BSL-2?

  1. The route of exposure (parenteral injection) bypasses natural protective barriers, increasing the effective risk. (correct answer)
  2. Attenuated vaccine strains can revert to virulence, posing a BSL-3 level threat to the community.
  3. Any work conducted within the physical space of a BSL-3 laboratory must follow all BSL-3 practices and procedures.
  4. The use of sharps with infectious agents is prohibited at BSL-2 and requires a move to BSL-3 containment.
Explanation: The correct answer is A. A biosafety risk assessment considers not only the intrinsic hazard of the agent (its Risk Group) but also the procedures being performed. A needlestick injury constitutes a parenteral exposure, which is a highly efficient route of infection that bypasses mucosal and skin barriers. While the attenuated agent itself may be RG-2, the high probability of infection via this unnatural route can elevate the overall risk of the procedure to a level requiring higher containment practices, such as those found at BSL-3, to protect the worker. The risk of the procedure must be considered alongside the risk of the agent. B is a theoretical possibility but is generally a very rare event and not the primary driver for the containment decision in this context. C is a correct statement of policy (you operate the lab at its designated level) but does not explain the underlying biosafety principle for why this specific work might require higher containment. It's the 'what' not the 'why'. D is incorrect. The use of sharps is not prohibited at BSL-2, but it is strongly discouraged and requires rigorous controls and safety-engineered devices.

Question 7

A new BSL-3 laboratory is undergoing its initial certification. A critical test involves sealing the room and pressurizing it with a gas to measure the decay rate over time. What is the primary purpose of this room integrity or 'sealability' test?

  1. To confirm that the room is sufficiently airtight to contain a gaseous decontaminant, such as formaldehyde or VHP. (correct answer)
  2. To verify that the directional airflow from clean to contaminated areas can be maintained under normal operating conditions.
  3. To ensure that the HEPA filtration units on the exhaust are functioning correctly and removing all particulates.
  4. To prove that the interlocking door system prevents both doors from being open simultaneously.
Explanation: When you encounter questions about BSL-3 laboratory certification procedures, focus on understanding what each specific test is designed to verify. The room integrity or "sealability" test described here involves pressurizing a sealed room with gas and measuring how quickly that pressure decays over time. This test directly measures how airtight the laboratory is, which is critical for containing gaseous decontaminants like formaldehyde vapor or vaporized hydrogen peroxide (VHP). These decontaminants are essential for sterilizing BSL-3 facilities, but they only work effectively if the room can maintain sufficient gas concentrations for the required contact time. If the room leaks, the decontaminant escapes before it can properly sterilize all surfaces and equipment. Option B is incorrect because directional airflow testing requires the ventilation system to be running, not a sealed room with static gas pressure. Option C addresses HEPA filter performance, which would be tested by introducing test particles while the system operates normally, not by sealing the room and using gas decay measurements. Option D involves mechanical testing of door interlocks, which doesn't require gas pressurization or decay rate analysis. The key distinction is that gas decay rate specifically measures containment capability under static conditions, which directly correlates to the room's ability to maintain effective concentrations of gaseous decontaminants during sterilization procedures. Remember: BSL laboratory tests are highly specific to their intended safety functions. When you see pressure decay or gas containment testing, think decontamination effectiveness rather than airflow patterns or equipment function.

Question 8

A research protocol involves infecting mice with Yersinia pestis and subsequently harvesting tissues for analysis. The work is conducted in an Animal Biosafety Level 3 (ABSL-3) facility. Which of the following practices is unique to ABSL-3 as compared to a standard BSL-3 laboratory?

  1. All manipulations of infectious materials must be performed in a certified Class II Biosafety Cabinet.
  2. Personnel must shower before exiting the animal facility containment area.
  3. Animal caging must be designed to contain aerosols and filter exhaust air before it enters the room. (correct answer)
  4. The facility must have directional airflow and a pass-through autoclave for decontaminating waste.
Explanation: The correct answer is C. The key challenge in animal biosafety, especially at high containment, is that the animals themselves can generate infectious aerosols through respiration, urination, and defecation. Therefore, a primary difference in ABSL-3 is the requirement for specialized animal housing. This often involves individually ventilated cage (IVC) systems where the air supplied to and exhausted from each cage is HEPA filtered. This contains the hazard at the source (the animal), which is a consideration not present in a standard BSL-3 lab working only with cell cultures. A is not unique; this practice is standard in BSL-3. B is a practice typically associated with BSL-4 or some animal facilities handling specific pathogens, but it is not a universal ABSL-3 requirement. D describes standard BSL-3 facility design features and is not unique to the animal component.

Question 9

A laboratory is preparing to ship a culture isolate of Coccidioides immitis to a reference laboratory for confirmation. This agent is classified as a Category A infectious substance. Which of the following is a key requirement for packaging this sample that distinguishes it from packaging a Category B substance?

  1. The sample must be placed in a sealed, leak-proof primary container, which is then placed in a leak-proof secondary container.
  2. The outer packaging must bear a Class 6, Division 6.2 infectious substance label.
  3. Sufficient absorbent material must be placed between the primary and secondary containers to absorb the entire liquid volume.
  4. The shipment must be accompanied by a shipper's declaration of dangerous goods and use UN 2814 certified packaging. (correct answer)
Explanation: When you encounter questions about shipping infectious agents, the key distinction is understanding the regulatory differences between Category A and Category B infectious substances. Category A agents pose extreme danger and require the most stringent shipping protocols. Coccidioides immitis is correctly classified as Category A because it's highly infectious and can cause severe disease. The distinguishing requirement for Category A substances is that they must be shipped with a shipper's declaration of dangerous goods and use UN 2814 certified packaging. This declaration is a formal document that provides detailed information about the dangerous goods being shipped, and UN 2814 specifically designates packaging tested and certified for Category A infectious substances affecting humans. Let's examine why the other options don't distinguish Category A from Category B: Option A describes basic containment requirements (sealed primary container in leak-proof secondary container) that apply to both categories. Option B mentions Class 6, Division 6.2 labeling, which is required for both Category A and B substances - it's not unique to Category A. Option C addresses absorbent material placement, which is a general safety requirement for liquid specimens in both categories, not a Category A distinguishing feature. The correct answer is D because only Category A substances require the formal shipper's declaration and UN 2814 certified packaging, while Category B substances can use UN 3373 packaging without the declaration. Study tip: Remember that Category A = "Affecting humans" = UN 2814 + shipper's declaration required. Category B = "Biological substance" = UN 3373 + no declaration needed. The documentation requirements are the key differentiator.

Question 10

A researcher is planning an experiment involving the use of a lentiviral vector to create a stable cell line. The vector is derived from HIV-1, is replication-incompetent, and carries a non-oncogenic reporter gene. The work will be performed in a standard tissue culture laboratory. According to NIH guidelines, what is the most appropriate minimum Biosafety Level (BSL) for this work?

  1. BSL-1, because the vector is replication-incompetent and cannot cause a productive infection.
  2. BSL-2, because the vector is derived from a human pathogen and could integrate into the host cell genome. (correct answer)
  3. BSL-3, because the parent virus, HIV-1, is a BSL-3 agent that requires high containment.
  4. BSL-2 with BSL-3 practices, because of the theoretical risk of recombination to form a replication-competent virus.
Explanation: The correct answer is B. Work with most replication-incompetent lentiviral vectors derived from HIV-1 is designated as BSL-2. The risk assessment considers that while the vector cannot replicate on its own, it is derived from a human pathogen (Risk Group 3) and retains the ability to transduce human cells and integrate its genetic material into the host genome, which is an inherent biohazard. BSL-2 practices and facilities are deemed sufficient to protect personnel and the environment from this risk. A is incorrect because the ability to integrate into the human genome, even without replication, is considered a significant enough hazard to require more than BSL-1 precautions. C is incorrect because the risk is determined by the properties of the vector itself, not the parent virus from which it was derived. Since the vector is engineered to be replication-incompetent, the high-containment requirements for the wild-type virus do not apply. D is incorrect because this 'BSL-2+' level of containment is typically reserved for situations with higher risk, such as creating vectors with oncogenes, performing large-scale productions, or if there is a realistic possibility of generating replication-competent lentivirus (RCL). For standard, small-scale work with a non-oncogenic reporter, BSL-2 is the established minimum.

Question 11

A research laboratory is being upgraded from BSL-2 to BSL-3 to work with a newly isolated avian influenza virus with documented human-to-human transmission. Which of the following facility modifications represents a fundamental shift in the containment strategy required for this upgrade?

  1. Installation of an autoclave within the laboratory suite to decontaminate waste before removal.
  2. Implementation of a controlled access system, such as a key card entry, for the main laboratory door.
  3. Creation of a dedicated anteroom with self-closing, interlocking doors to maintain directional airflow. (correct answer)
  4. Replacing all open-fronted benchtops with Class II Biosafety Cabinets for all experimental work.
Explanation: The correct answer is C. The defining feature of a BSL-3 facility, distinguishing it from BSL-2, is the strict control over air movement to create directional airflow from 'clean' areas to 'contaminated' areas. This is achieved through a dedicated anteroom (or airlock) that separates the lab from adjacent spaces, often with interlocking doors. This design element is a core part of secondary containment, preventing the escape of hazardous aerosols from the laboratory itself. A is incorrect because while having an autoclave in the lab is a common and recommended feature for BSL-3 to minimize transport of contaminated materials, it is also a feature of many enhanced BSL-2 labs. It is a best practice, but not the most fundamental architectural shift in containment philosophy from BSL-2 to BSL-3. B is incorrect because controlled access is required at BSL-2 as well, although the stringency may increase at BSL-3. It is not the key differentiator. D is incorrect because Class II BSCs are the primary containment devices used in both BSL-2 and BSL-3 labs for aerosol-generating procedures. While BSL-3 requires all open manipulations of the agent to be done in a BSC, the presence of BSCs themselves is not unique to BSL-3.

Question 12

During annual certification of a Class II, Type A2 Biosafety Cabinet (BSC), a technician discovers that the HEPA filter for the exhausted air is compromised with a small tear. The BSC is currently used for routine propagation of Herpes Simplex Virus (HSV), a BSL-2 agent. What is the primary risk associated with this specific equipment failure?

  1. Risk to the experiment due to contamination of the cell cultures inside the cabinet with environmental microbes.
  2. Risk to the operator due to exposure to infectious aerosols generated within the work area.
  3. Risk to the environment outside the laboratory due to the release of unfiltered, infectious aerosols. (correct answer)
  4. Risk of a fire or electrical hazard due to altered airflow patterns affecting the cabinet's motor.
Explanation: The correct answer is C. A Class II, Type A2 BSC is designed to protect personnel, the product (experiment), and the environment. It does this by filtering both the downflow air (protecting the product) and the exhaust air (protecting the environment). A tear in the exhaust HEPA filter means that aerosols generated inside the cabinet are no longer being filtered before being discharged. In a Type A2 cabinet, a portion of this air (typically 30%) is exhausted back into the laboratory room. Therefore, the primary risk is the release of infectious HSV aerosols into the lab environment, potentially exposing other personnel. A is incorrect because the tear is in the exhaust filter, not the downflow filter that supplies clean air to the work surface. Product protection would be compromised if the downflow filter failed. B is incorrect because the protective airflow at the front opening of the cabinet (the air curtain) that protects the operator is primarily generated by the motor pulling air in and is not directly dependent on the integrity of the exhaust filter. While a major failure could disrupt patterns, the immediate and direct risk of this specific failure is environmental release. D is incorrect because while altered airflow can strain a motor, it is not the primary biosafety risk associated with a compromised HEPA filter.

Question 13

A clinical microbiology laboratory is processing a sputum sample from a patient with suspected active pulmonary tuberculosis. The procedure involves vortexing the sample in a capped tube to homogenize it before culture. A technician performs this task on an open bench while wearing a lab coat, gloves, and a standard surgical mask. Which of the following represents the most critical breach of biosafety protocol in this scenario?

  1. The use of a standard surgical mask is insufficient for respiratory protection against airborne particles.
  2. Vortexing a capped tube containing Mycobacterium tuberculosis should only be performed within a Class II Biosafety Cabinet. (correct answer)
  3. The sample should have been inactivated with a chemical disinfectant prior to any homogenization procedure.
  4. The technician is under-protected; a fluid-resistant gown and face shield are also required for processing sputum.
Explanation: The correct answer is B. Vortexing is a high-energy procedure that can create infectious aerosols, even in a capped tube, due to potential leakage or pressure changes. Mycobacterium tuberculosis is a Risk Group 3 pathogen transmitted via aerosols, requiring all procedures with the potential for aerosol generation to be performed in a primary containment device like a Class II Biosafety Cabinet (BSC). This is the most critical breach because it generates an immediate inhalation risk for the technician and contaminates the laboratory environment. A is incorrect because while an N95 respirator would be required inside the BSC for this procedure, the primary failure is not performing the work in the BSC in the first place. The BSC is the engineering control that contains the hazard at its source. C is incorrect because chemical inactivation may interfere with subsequent culture viability, which is the goal of this procedure. While inactivation is used for some downstream applications (e.g., molecular testing), it is not standard practice before culture. D is incorrect because while enhanced PPE might be part of a lab's specific protocol, the fundamental failure is the lack of primary engineering containment (the BSC), which poses a far greater risk than the absence of a gown or face shield for this specific procedure.

Question 14

The CDC's Select Agent Program imposes requirements beyond those dictated solely by an agent's Risk Group and BSL designation. A facility that handles Bacillus anthracis (a Select Agent) must implement which of the following administrative controls that is not required for a facility handling an otherwise equivalent BSL-3 non-select agent?

  1. Maintaining detailed logs of all personnel who access the BSL-3 laboratory.
  2. Requiring personnel to receive specialized training on the hazards of the specific agent.
  3. Developing a comprehensive emergency response plan for spills and personnel exposures.
  4. Undergoing a security risk assessment and clearance for all personnel with access to the agent. (correct answer)
Explanation: The correct answer is D. The Select Agent Program is primarily concerned with biosecurity (preventing theft, loss, or intentional misuse of dangerous pathogens) in addition to biosafety. A key requirement of this program is that all individuals with access to Select Agents must undergo a Security Risk Assessment (SRA) conducted by the Department of Justice/FBI. This is a unique administrative control that does not apply to non-select agents, even those handled at the same biosafety level. A, B, and C are all standard and essential components of a robust biosafety program for any BSL-3 laboratory, regardless of whether the agent is a Select Agent or not. While the stringency and documentation may be higher for Select Agents, the requirement for access logs, specific training, and emergency plans is fundamental to all BSL-3 work.

Question 15

A fire alarm is activated in a building that houses a BSL-4 suit laboratory. Personnel are inside the maximum containment area working with a lethal virus. The facility's emergency action plan must balance immediate life safety with biocontainment. Which of the following actions represents the most appropriate response for the personnel inside the BSL-4 lab?

  1. Immediately evacuate through the nearest emergency exit, bypassing all standard decontamination procedures.
  2. Secure all infectious materials in a BSC, power down non-essential equipment, and proceed through the standard chemical decontamination shower exit. (correct answer)
  3. Move to a designated 'safe room' within the containment zone and await instructions from emergency responders.
  4. Initiate emergency whole-room fumigation to neutralize the agent before evacuating through the chemical shower.
Explanation: The correct answer is B. Emergency plans for BSL-4 labs are complex and highly specific, but they are built on the principle of a safe and controlled exit whenever possible. The standard procedure in the event of a fire alarm (in the absence of immediate, direct personal danger like flames in the room) is to follow a controlled shutdown. This involves securing agents, shutting down BSCs, and exiting via the mandatory chemical shower to decontaminate the positive-pressure suits. This process is practiced to be as rapid as possible while maintaining containment. A is incorrect. Bypassing decontamination would risk releasing the BSL-4 agent into the environment, which could cause a public health catastrophe. This is only considered in the most extreme, life-or-death situations where the exit path is compromised. C is incorrect. While waiting for instructions might seem prudent, it delays evacuation in a potential fire. The protocol is to initiate a controlled exit. D is incorrect because whole-room fumigation takes hours and would be completely inappropriate during a fire emergency.

Question 16

A research laboratory is being upgraded from BSL-2 to BSL-3 to work with a newly isolated avian influenza virus with documented human-to-human transmission. Which of the following facility modifications represents a fundamental shift in the containment strategy required for this upgrade?

  1. Installation of an autoclave within the laboratory suite to decontaminate waste before removal.
  2. Implementation of a controlled access system, such as a key card entry, for the main laboratory door.
  3. Creation of a dedicated anteroom with self-closing, interlocking doors to maintain directional airflow. (correct answer)
  4. Replacing all open-fronted benchtops with Class II Biosafety Cabinets for all experimental work.
Explanation: The correct answer is C. The defining feature of a BSL-3 facility, distinguishing it from BSL-2, is the strict control over air movement to create directional airflow from 'clean' areas to 'contaminated' areas. This is achieved through a dedicated anteroom (or airlock) that separates the lab from adjacent spaces, often with interlocking doors. This design element is a core part of secondary containment, preventing the escape of hazardous aerosols from the laboratory itself. A is incorrect because while having an autoclave in the lab is a common and recommended feature for BSL-3 to minimize transport of contaminated materials, it is also a feature of many enhanced BSL-2 labs. It is a best practice, but not the most fundamental architectural shift in containment philosophy from BSL-2 to BSL-3. B is incorrect because controlled access is required at BSL-2 as well, although the stringency may increase at BSL-3. It is not the key differentiator. D is incorrect because Class II BSCs are the primary containment devices used in both BSL-2 and BSL-3 labs for aerosol-generating procedures. While BSL-3 requires all open manipulations of the agent to be done in a BSC, the presence of BSCs themselves is not unique to BSL-3.

Question 17

A researcher is planning an experiment involving the use of a lentiviral vector to create a stable cell line. The vector is derived from HIV-1, is replication-incompetent, and carries a non-oncogenic reporter gene. The work will be performed in a standard tissue culture laboratory. According to NIH guidelines, what is the most appropriate minimum Biosafety Level (BSL) for this work?

  1. BSL-1, because the vector is replication-incompetent and cannot cause a productive infection.
  2. BSL-2, because the vector is derived from a human pathogen and could integrate into the host cell genome. (correct answer)
  3. BSL-3, because the parent virus, HIV-1, is a BSL-3 agent that requires high containment.
  4. BSL-2 with BSL-3 practices, because of the theoretical risk of recombination to form a replication-competent virus.
Explanation: The correct answer is B. Work with most replication-incompetent lentiviral vectors derived from HIV-1 is designated as BSL-2. The risk assessment considers that while the vector cannot replicate on its own, it is derived from a human pathogen (Risk Group 3) and retains the ability to transduce human cells and integrate its genetic material into the host genome, which is an inherent biohazard. BSL-2 practices and facilities are deemed sufficient to protect personnel and the environment from this risk. A is incorrect because the ability to integrate into the human genome, even without replication, is considered a significant enough hazard to require more than BSL-1 precautions. C is incorrect because the risk is determined by the properties of the vector itself, not the parent virus from which it was derived. Since the vector is engineered to be replication-incompetent, the high-containment requirements for the wild-type virus do not apply. D is incorrect because this 'BSL-2+' level of containment is typically reserved for situations with higher risk, such as creating vectors with oncogenes, performing large-scale productions, or if there is a realistic possibility of generating replication-competent lentivirus (RCL). For standard, small-scale work with a non-oncogenic reporter, BSL-2 is the established minimum.

Question 18

A laboratory must select a chemical disinfectant for use on work surfaces in a BSL-3 facility where Mycobacterium tuberculosis and various non-enveloped viruses are handled. The lab manager is considering four options. Which of the following disinfectants is most likely to be inadequate for the spectrum of organisms being handled?

  1. A 10% solution of household bleach (0.5-0.6% sodium hypochlorite) prepared fresh daily.
  2. An accelerated hydrogen peroxide proprietary formulation registered as a tuberculocidal.
  3. A quaternary ammonium compound-based disinfectant listed as effective against bacteria and enveloped viruses. (correct answer)
  4. A 70% ethanol solution used for wiping down surfaces after a primary disinfection step.
Explanation: The correct answer is C. Quaternary ammonium compounds ('quats') are low-level disinfectants. While they are effective against some bacteria and enveloped viruses, they are generally not effective against mycobacteria (like M. tuberculosis), which have a waxy cell wall, or non-enveloped viruses, which are more resistant to disinfection. Therefore, this choice would be inadequate for the required spectrum of activity in this BSL-3 setting. A is a correct choice. A 10% bleach solution is a broad-spectrum, intermediate-to-high-level disinfectant effective against bacteria, viruses (both enveloped and non-enveloped), and mycobacteria. B is a correct choice. Accelerated hydrogen peroxide is an intermediate-level disinfectant with excellent activity against a broad range of pathogens, including mycobacteria and non-enveloped viruses. D is a correct choice in its described role. While 70% ethanol is an intermediate-level disinfectant, it is often used as a secondary step after cleaning with a detergent or a primary disinfectant like bleach, as it evaporates quickly and leaves no residue. It has good activity but can be less effective in the presence of heavy organic loads, hence its use as a secondary wipe.

Question 19

A clinical laboratory receives a sealed, intact blood culture bottle that flags positive. A Gram stain reveals gram-negative rods. The lab's standard operating procedure is to subculture the bottle in a BSL-2 facility. However, if the isolate is later identified as Francisella tularensis, an unexpected BSL-3 agent, which initial step in processing posed the greatest risk of a laboratory-acquired infection?

  1. Performing the Gram stain, which involves heat-fixing the slide on a slide warmer.
  2. Inserting a needle into the septum of the blood culture bottle to withdraw an aliquot for subculture.
  3. Streaking the withdrawn blood onto agar plates on an open bench. (correct answer)
  4. Uncapping the positive blood culture bottle to perform a direct MALDI-TOF identification.
Explanation: The correct answer is C. Streaking an inoculum onto an agar plate is a common procedure that can generate infectious aerosols, especially with a loop or needle. When dealing with an unknown but potentially high-risk pathogen like F. tularensis (which has a very low infectious dose via inhalation), performing this manipulation on an open bench creates a significant risk of exposure for the technologist. All unknown positive blood cultures should ideally be subcultured within a BSC. A is a lower risk. While heat-fixing can create some aerosols, the number of viable organisms aerosolized is typically much lower than during culture manipulation. B is a relatively low-risk procedure. Using a needle and syringe through a rubber septum is designed to minimize aerosol production and is a standard, safe technique. D, while also a manipulation with an open bottle, is often performed on a small spot and is a less vigorous action than streaking a plate, which involves moving the inoculum across a wide surface area. However, the most fundamental and high-risk procedure among the choices that is routinely performed is the open-bench subculture (streaking).

Question 20

A research protocol involves infecting mice with Yersinia pestis and subsequently harvesting tissues for analysis. The work is conducted in an Animal Biosafety Level 3 (ABSL-3) facility. Which of the following practices is unique to ABSL-3 as compared to a standard BSL-3 laboratory?

  1. All manipulations of infectious materials must be performed in a certified Class II Biosafety Cabinet.
  2. Personnel must shower before exiting the animal facility containment area.
  3. Animal caging must be designed to contain aerosols and filter exhaust air before it enters the room. (correct answer)
  4. The facility must have directional airflow and a pass-through autoclave for decontaminating waste.
Explanation: The correct answer is C. The key challenge in animal biosafety, especially at high containment, is that the animals themselves can generate infectious aerosols through respiration, urination, and defecation. Therefore, a primary difference in ABSL-3 is the requirement for specialized animal housing. This often involves individually ventilated cage (IVC) systems where the air supplied to and exhausted from each cage is HEPA filtered. This contains the hazard at the source (the animal), which is a consideration not present in a standard BSL-3 lab working only with cell cultures. A is not unique; this practice is standard in BSL-3. B is a practice typically associated with BSL-4 or some animal facilities handling specific pathogens, but it is not a universal ABSL-3 requirement. D describes standard BSL-3 facility design features and is not unique to the animal component.